in

Anticoagulants do not reduce arterial thrombotic event risk in cancer

Anticoagulants do not reduce arterial thrombotic event risk in cancer

For ambulatory patients on systemic anticancer therapy, anticoagulants do not reduce the risk of arterial thrombotic events (ATEs) and are associated with increased bleeding risk, according to a review published online June 27 in JACC: CardioOncology.

Read the full post

Written by Editor

England keep Ashes series alive with win over Australia

Pictures of Terry and Lisa, and of Terry holding their baby

‘I lost my father and became a dad all within 24 hours’